Corify Care introduces first whole-heart mapping technology, providing complete picture of cardiac arrhythmias in a single beat

Newswise — Madrid, January 28, 2026 — Corify Care today announced a major advancement in cardiac electrophysiology with the launch of its proprietary global volume mapping technology. nature communication medicine. This publication demonstrates the first system that can map all four heart chambers at once, providing physicians with a complete, real-time view of arrhythmias that current solutions cannot provide.

Corify Care introduces first whole-heart mapping technology, providing complete picture of cardiac arrhythmias in a single beat

Today’s mapping systems analyze the heart one chamber at a time, forcing clinicians to infer what they can’t see. Corify Care’s system changes that paradigm by mapping the surface of the heart, allowing visualization inside the heart wall and septum for the first time. The Corify system provides a single-beat, whole-heart map that reveals how arrhythmias travel through the heart wall and across the ventricles before and during ablation.

“This is about visibility and trust,” said Dr. Andreu Climent, CEO of Corify Care. “We provide physicians with a complete picture upfront, rather than piecemeal. A holistic view means faster decision-making, more targeted ablation, and the potential to reduce procedure time and complexity and provide clinical clarity.”

Designed for the EP Lab of the future

Corify Care’s system reveals arrhythmia pathways that are often missed by traditional tools, such as circuits located deep within the heart wall or spanning multiple ventricles. By eliminating blind spots, the platform helps physicians address complex cases more efficiently and predictably.

“For the first time, we can non-invasively observe how the heart actually works on a global scale,” said Chief Medical Officer Felipe Atienza, MD. “This has important implications for EP lab workflow, outcomes, and scalability.”

Dr. Jorge Vicente Puig, The lead author added, “Our study shows that volumetric approaches are essential for true arrhythmia characterization. We went beyond previous mathematical limitations to provide a complete 3D physiological image.”

The ACORYS® System is CE marked and currently undergoing FDA review to meet regulatory requirements for the US market. Corify Care is actively integrating with leading catheter navigation platforms to enable seamless hybrid workflows. Corify Care will present new clinical data on the application of global volume mapping for atrial fibrillation and ventricular tachycardia at the 2026 AF Symposium in Boston this February.

About Corify Care

Corify Care is a MedTech company redefining cardiac mapping with non-invasive whole-heart visualization. Its technology integrates seamlessly into existing EP workflows, helping clinicians treat complex arrhythmias more reliably and efficiently.

Links to nature studies: https://www.nature.com/articles/s43856-025-01332-5

Media contact: gestion@corify.es;Andrew M. Kliment

Corify Care logo

Latest Update